Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
4.730
+0.240 (5.35%)
Aug 4, 2026, 1:29 PM EDT - Market open
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $15.17 million as of August 4, 2026. Its market cap has decreased by -14.93% in one year.
Market Cap
15.17M
Enterprise Value
-13.18M
1-Year Change
-14.93%
Ranking
Category
Stock Price
$4.73
ChartMarket Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $15.17M, a decrease of -98.41%. That is a compound annual growth rate of -47.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 15.17M | -59.55% |
| Dec 31, 2025 | 37.51M | 7.08% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Citius Pharmaceuticals | 15.65M |
| Pasithea Therapeutics | 15.37M |
| NextCure | 14.97M |
| Vyome Holdings | 14.84M |
| Cyclerion Therapeutics | 14.59M |
| KALA BIO | 14.05M |
| Moolec Science | 14.00M |
| Akari Therapeutics, | 13.76M |